An anti-human immunodeficiency virus multiple antigen peptide encompassingthe cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step

CLIV is a multiple antigen peptide ([PTKAKRRVVQREKR](4)-K-2-K-beta A) that encompasses the cleavage region of the human immunodeficiency virus type 1 (HIV-I) envelope precursor. II displays an antiviral activity against HIV-1 and HIV-2 and inhibits HIV-1 Env-mediated cell-to-cell fusion. This effect has previously been attributed to interference with Env processing, result ing in the expression of a nonfusogenic envelope [Virology ( 1998) 247, 137 ]. However, we show here that CLIV does not alter the status of Env cleavag e at steady state. Using various aggregation/syncytium assays that allow us to discriminate between gp120/CD4 binding and binding followed by gp41-med iated fusion, we demonstrate that CLIV inhibits a step of the cell-to-cell fusion process after CD4 binding. We demonstrate also that CLIV binds at 37 degrees C to a single class of protein present at the CD4(+) cell surface (Scatchard analysis: K-d = 8 nM; B-max = 10(4) sites/cell) and that the fus ion inhibition activity seems to correlate with binding to this proteic com ponent. In contrast, CLIV interacts with neither membrane-inserted nor CD4- associated Env. We therefore propose that CLIV interferes after Env/CD4 bin ding with a step of the membrane fusion process that may involve the C-term inal domain of gp120. (C) 2000 Academic Press.